ZeroStack Corp. - Common Stock (ZSTK)
Industrials › Wholesale-Drugs, Proprietaries & Druggists' Sundries
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 0.29 — trading below book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -19.3%
- Revenue declining 40% annually
ZeroStack Corp. - Common Stock (ZSTK) is a Industrials company operating in Wholesale-Drugs, Proprietaries & Druggists' Sundries, listed on the NASDAQ , with a market capitalisation of $20 million . Key value metrics: P/B ratio 0.29, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
ZeroStack Corp. - Common Stock — Fundamental Analysis Summary
On financial health, ZSTK shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -19.3% (sector average: 5.5%), and manageable leverage with a debt-to-equity ratio of 0.76.
StockPik's composite Value Score for ZSTK is 53/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ZSTK reports a thin gross margin of 18.2% (sector average: 24.7%) and a negative operating margin of -21.5%.
ZSTK shows revenue declining at 40% year-over-year, with earnings declining at 653%.